Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.53 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.50 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | CTSD | P07339 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.47 |
| ▸ | HTR7 | P34969 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29551674 | 1.00 | CA12 (0.61) | CA12CA1CA2CA9TSHR | |
| SCHEMBL29551646 | 0.97 | CA12 (0.59) | CA12CA1CA2CA9TSHR | |
| SCHEMBL4541662 | 0.97 | CA12 (0.59) | CA12CA1CA2CA9TSHR | |
| SCHEMBL3294993 | 0.92 | CA12 (0.55) | CA12CA1CA2CA9TSHR | |
| Tannin Pyrogallol SCHEMBL28281926 | 0.92 | CA12 (0.55) | CA12CA1CA2CA9TSHR | |
| SCHEMBL1047559 | 0.92 | CA12 (0.55) | CA12CA1CA2CA9TSHR | |
| SCHEMBL616 | 0.91 | ESR2 (0.54) | CA12CA1CA2CA9TSHR | |
| SCHEMBL29706107 | 0.91 | ESR2 (0.54) | CA12CA1CA2CA9TSHR | |
| SCHEMBL30612770 | 0.91 | CA12 (0.54) | CA12CA1CA2CA9TSHR | |
| Hydrogen Sulfide SCHEMBL27694678 | 0.89 | CA12 (0.53) | CA12CA1CA2CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250290918-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | JUNO THERAPEUTICS, INC. (US) | 2025-09-18 | — | — | US | disclosed |
| US-12379375-B2 | Methods for assessing cell surface glycosylation | JUNO THERAPEUTICS, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| EP-3507263-B1 | EFFICIENT CATALYST FOR THE FORMATION OF POLYARYL HYDROCARBONS SUITABLE AS PRECURSORS FOR POLYDENTATE ORGANOPHOSPHORUS CATALYST LIGANDS | EASTMAN CHEM CO (US) | 2024-06-19 | — | — | EP | disclosed |
| US-20240159743-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | JUNO THERAPEUTICS, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-11796534-B2 | Methods for assessing cell surface glycosylation | JUNO THERAPEUTICS, INC. (US) | 2023-10-24 | — | — | US | disclosed |
| US-11448652-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210255173-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | JUNO THERAPEUTICS, INC. (US) | 2021-08-19 | — | — | US | disclosed |
| US-20200174008-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION | 2020-06-04 | — | — | US | disclosed |
| EP-3610261-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | Juno Therapeutics, Inc. (US) | 2020-02-19 | — | — | EP | disclosed |
| US-10436790-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2019-10-08 | — | — | US | disclosed |
| EP-2148701-A2 | IMAGING CONTRAST AGENTS USING NANOPARTICLES | Carestream Health, Inc. (US) | 2010-02-03 | — | — | EP | disclosed |
| US-20090169482-A1 | SILICA-CORED CARRIER PARTICLE | QUANTUM MEDICAL HOLDINGS, LLC | 2009-07-02 | — | — | US | disclosed |
| US-20090098057-A1 | SILICA-CORED CARRIER PARTICLE | QUANTUM MEDICAL IMAGING, L.L.C. | 2009-04-16 | — | — | US | disclosed |
| WO-2008140475-A2 | IMAGING CONTRAST AGENTS USING NANOPARTICLES | CARESTREAM HEALTH, INC. (US) | 2008-11-20 | — | — | WO | disclosed |
| US-20080095699-A1 | IMAGING CONTRAST AGENTS USING NANOPARTICLES | CARESTREAM HEALTH, INC. | 2008-04-24 | — | — | US | disclosed |
| US-7151623-B2 | Holographic data-storage medium | TESA SCRIBOS GMBH (DE) | 2006-12-19 | — | — | US | disclosed |
| EP-1395985-B1 | HOLOGRAPHIC DATA-STORAGE MEDIUM | TESA SCRIBOS GMBH (DE) | 2006-09-06 | — | — | EP | disclosed |
| US-6844963-B2 | Double-resonance-absorption microscope | OLYMPUS OPTICAL CO., LTD. (JP) | 2005-01-18 | — | — | US | disclosed |
| US-6667830-B1 | Super-resolution microscope system and method for illumination | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2003-12-23 | — | — | US | disclosed |
| US-20010045529-A1 | Double-resonance-absorption microscope | OLYMPUS CORPORATION (JP) | 2001-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080095699-A1 | IMAGING CONTRAST AGENTS USING NANOPARTICLES | CD47, MSN, CLTA | CA12 170/4885CA1 381/4885CA2 2336/4885 |
| US-11448652-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | FUT5, FUT6, CSGALNACT1 | CA12 1624/4885CA1 3592/4885CA2 4464/4885 |
| US-20200174008-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | FUT5, FUT6, CSGALNACT1 | CA12 1360/4885CA1 3747/4885CA2 4542/4885 |
| US-10436790-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | FUT5, FUT6, CSGALNACT1 | CA12 911/4885CA1 3310/4885CA2 4544/4885 |
| US-20090098057-A1 | SILICA-CORED CARRIER PARTICLE | MSN, CD44, SND1 | CA12 14/4885CA1 22/4885CA2 1253/4885 |
| US-20090169482-A1 | SILICA-CORED CARRIER PARTICLE | MSN, CD44, SND1 | CA12 14/4885CA1 22/4885CA2 1253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.